← Back to directory

Stefania Pittaluga

Researcher Next ID · RN-022485

Researcher · Medicine

National Institutes of Health

Bethesda, Malaysia

Not currently recruitingFunding unknown
Works count
803
Citation count
46,712
H-index
116
i10-index
381

Research interests

Medicine
Immunology and Microbiology
Lymphoma Diagnosis and Treatment
Chronic Lymphocytic Leukemia Research
Viral-associated cancers and disorders
Immune Cell Function and Interaction
CAR-T cell therapy research

Publications

  • SARS-CoV-2 infection and persistence in the human body and brain at autopsy

    Nature · 2022 · https://doi.org/10.1038/s41586-022-05542-y

  • SARS-CoV-2 infection of the oral cavity and saliva

    Nature Medicine · 2021 · 10.1038/s41591-021-01296-8

  • Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series

    EClinicalMedicine · 2020 · 10.1016/j.eclinm.2020.100434

  • Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

    New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1801445

  • A multiprotein supercomplex controlling oncogenic signalling in lymphoma

    Nature · 2018 · 10.1038/s41586-018-0290-0

  • Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia

    Blood · 2017 · 10.1182/blood-2016-06-719294

  • Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI

    eLife · 2017 · 10.7554/elife.29738

  • Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

    Cancer Cell · 2017 · 10.1016/j.ccell.2017.04.012

  • Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study

    The Lancet Oncology · 2015 · 10.1016/s1470-2045(15)70106-3

  • Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

    Nature Medicine · 2015 · https://doi.org/10.1038/nm.3884

  • Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial

    The Lancet Oncology · 2014 · 10.1016/s1470-2045(14)71182-9

  • Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4

    Science · 2014 · https://doi.org/10.1126/science.1255904

  • B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma

    Clinical Cancer Research · 2013 · 10.1158/1078-0432.ccr-12-2422

  • Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma

    New England Journal of Medicine · 2013 · 10.1056/nejmoa1214561

  • Low-Intensity Therapy in Adults with Burkitt's Lymphoma

    New England Journal of Medicine · 2013 · 10.1056/nejmoa1308392

  • Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency

    Nature Immunology · 2013 · 10.1038/ni.2771

  • Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

    Nature · 2012 · https://doi.org/10.1038/nature11378

  • Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome

    Blood · 2011 · 10.1182/blood-2011-05-356352

  • The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia

    Blood · 2010 · 10.1182/blood-2010-05-284984

  • Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections

    PLoS Pathogens · 2010 · 10.1371/journal.ppat.1001052

  • EBV Positive Mucocutaneous Ulcer—A Study of 26 Cases Associated With Various Sources of Immunosuppression

    The American Journal of Surgical Pathology · 2010 · 10.1097/pas.0b013e3181cf8622

  • Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

    Blood · 2009 · 10.1182/blood-2009-01-199679

  • Diffuse Large B-cell Lymphomas With Plasmablastic Differentiation Represent a Heterogeneous Group of Disease Entities

    The American Journal of Surgical Pathology · 2004 · 10.1097/01.pas.0000126781.87158.e3

  • Highly effective treatment of acquired immunodeficiency syndrome–related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology

    Blood · 2003 · 10.1182/blood-2002-11-3589

  • Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1

    Blood · 2002 · 10.1182/blood.v99.8.2703

Current projects

    No projects listed.